bioRxivBioinformaticsPreprint
TargetSeeker-MS: A computational method for drug target discovery using protein separation coupled to mass spectrometry
Mathieu Lavallée‐AdamiD, Alexander R. PelletieriD, Jolene K. DiedrichiD, William Low, Antônio F. M. PintoiD, Salvador Martínez‐BartoloméiD, Michael PetrascheckiD, James J. MorescoiD, John R. YatesiD
Abstract
When coupled to mass spectrometry (MS), energetics-based protein separation (EBPS) techniques, such as thermal shift assay, have shown great potential to identify the targets of a drug on a proteome scale. Nevertheless, the computational analyses assessing the confidence of drug target predictions made by these methods have remained rudimentary and significantly differ depending on the protocol used to produce the data. To identify drug targets in datasets produced using different EBPS-MS techniques, we have developed a novel flexible computational approach named TargetSeeker-MS. We showed that TargetSeeker-MS reproducibly identifies known and novel drug targets in C. elegans and HEK293 samples that were treated with the fungicide benomyl and processed using two different EBPS techniques. We also validated a novel benomyl target in vitro. TargetSeeker-MS, which is available online, allows for the confident identification of targets of a drug on a proteome scale, thereby facilitating the evaluation of its clinical viability.
- organism: C. elegans
- organism: human
- assay: proteomics
- research focus: drug response / drug discovery
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- LiP-Quant, an automated chemoproteomic approach to identify drug targets in complex proteomes
Ilaria Piazza, Nigel Beaton, … Lukas Reiter·bioRxiv·Dec 1, 2019
- Assessing target engagement using proteome-wide solvent shift assays
J. G. Van Vranken, J. Li, … S. P. Gygi·bioRxiv·Jul 22, 2021
- MaxQuant.Live enables global targeting of more than 25,000 peptides
Christoph Wichmann, Florian Meier, … Matthias Mann·Molecular & Cellular ProteomicsPeer-reviewed·Feb 12, 2019
- PhenoMS-ML: Phenotypic Screening by Mass Spectrometry and Machine Learning
L. N. van Oosten, C. D. Klein·bioRxiv·Mar 30, 2019
- Rapid discovery of drug target engagement by isothermal shift assay
K. J. Webb, K. A. Ball, … W. M. Old·bioRxiv·Apr 5, 2019
- ProteomeScan: A Toolkit For Target Validation By Proteome-Wide Docking And Analysis
Aryan Amit Barsainyan, Rishikesh Panda, … Bharath Ramsundar·bioRxiv·Apr 16, 2026